Zagon et al. [22] found that KCNQ1OT1/miR-214/caspase-1 signaling pathway represents a new mechanism for the progression of endothelial keratopathy in diabetes, and KCNQ1OT1 may be a new therapeutic target. This evidence concerns the gene KCNQ1OT1 and diabetes mellitus.